129 related articles for article (PubMed ID: 25033730)
21. Decreased expression of microRNA-206 correlates with poor clinical outcome in patients with malignant astrocytomas.
Wang S; Lu S; Geng S; Ma S; Liang Z; Jiao B
Pathol Oncol Res; 2014 Apr; 20(2):343-8. PubMed ID: 24390803
[TBL] [Abstract][Full Text] [Related]
22. miR-34b targets cyclic AMP-responsive element binding protein in acute myeloid leukemia.
Pigazzi M; Manara E; Baron E; Basso G
Cancer Res; 2009 Mar; 69(6):2471-8. PubMed ID: 19258499
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-132 targets PEA-15 and suppresses the progression of astrocytoma in vitro.
Geng F; Wu JL; Lu GF; Liang ZP; Duan ZL; Gu X
J Neurooncol; 2016 Sep; 129(2):211-20. PubMed ID: 27294355
[TBL] [Abstract][Full Text] [Related]
24. Clinical significance of microRNA-93 downregulation in human colon cancer.
Xiao ZG; Deng ZS; Zhang YD; Zhang Y; Huang ZC
Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):296-301. PubMed ID: 23354160
[TBL] [Abstract][Full Text] [Related]
25. Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer.
Yang J; Liu H; Wang H; Sun Y
Pathol Res Pract; 2013 Aug; 209(8):490-4. PubMed ID: 23827213
[TBL] [Abstract][Full Text] [Related]
26. Reduced WWOX protein expression in human astrocytoma.
Winardi W; Tsai CY; Chen WT; Tsai HP; Chung CL; Loh JK; Chai CY; Kwan AL
Neuropathology; 2013 Dec; 33(6):621-7. PubMed ID: 23675860
[TBL] [Abstract][Full Text] [Related]
27. High expression of cAMP-responsive element-binding protein 1 (CREB1) is associated with metastasis, tumor stage and poor outcome in gastric cancer.
Wang YW; Chen X; Gao JW; Zhang H; Ma RR; Gao ZH; Gao P
Oncotarget; 2015 Apr; 6(12):10646-57. PubMed ID: 25825983
[TBL] [Abstract][Full Text] [Related]
28. Factors predicting progression of low-grade diffusely infiltrating astrocytoma.
Ranjan M; Santosh V; Tandon A; Anandh B; Sampath S; Devi BI; Chandramouli BA
Neurol India; 2011; 59(2):248-53. PubMed ID: 21483127
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical expression of cycloxygenase-2 in astrocytoma: correlation with angiogenesis, tumor progression and survival.
El-Sayed M; Taha MM
Turk Neurosurg; 2011 Jan; 21(1):27-35. PubMed ID: 21294088
[TBL] [Abstract][Full Text] [Related]
30. SOX4 is overexpressed in diffusely infiltrating astrocytoma and confers poor prognosis.
Li L; Li Q; Chen X; Xu M; Li X; Nie L; Chen N; Gong J; Mao Q; Zhou Q
Neuropathology; 2015 Dec; 35(6):510-7. PubMed ID: 26096696
[TBL] [Abstract][Full Text] [Related]
31. Pitfalls in the assessment of MGMT expression and in its correlation with survival in diffuse astrocytomas: proposal of a feasible immunohistochemical approach.
Capper D; Mittelbronn M; Meyermann R; Schittenhelm J
Acta Neuropathol; 2008 Feb; 115(2):249-59. PubMed ID: 17965865
[TBL] [Abstract][Full Text] [Related]
32. Downregulation of chromatin remodeling factor CHD5 is associated with a poor prognosis in human glioma.
Wang L; He S; Tu Y; Ji P; Zong J; Zhang J; Feng F; Zhao J; Gao G; Zhang Y
J Clin Neurosci; 2013 Jul; 20(7):958-63. PubMed ID: 23707602
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of IL-8-STAT-3 pathway in astrocytomas: correlation with IL-6, VEGF and microvessel morphometry.
Piperi C; Samaras V; Levidou G; Kavantzas N; Boviatsis E; Petraki K; Grivas A; Barbatis C; Varsos V; Patsouris E; Korkolopoulou P
Cytokine; 2011 Sep; 55(3):387-95. PubMed ID: 21684758
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of microRNA-223/epithelial cell transforming sequence 2 signaling in patients with osteosarcoma.
Zhang H; Yin Z; Ning K; Wang L; Guo R; Ji Z
Hum Pathol; 2014 Jul; 45(7):1430-6. PubMed ID: 24784921
[TBL] [Abstract][Full Text] [Related]
35. Minichromosome maintenance protein 3 elicits a cancer-restricted immune response in patients with brain malignancies and is a strong independent predictor of survival in patients with anaplastic astrocytoma.
Söling A; Sackewitz M; Volkmar M; Schaarschmidt D; Jacob R; Holzhausen HJ; Rainov NG
Clin Cancer Res; 2005 Jan; 11(1):249-58. PubMed ID: 15671553
[TBL] [Abstract][Full Text] [Related]
36. WT1 expression increases with malignancy and indicates unfavourable outcome in astrocytoma.
Rauscher J; Beschorner R; Gierke M; Bisdas S; Braun C; Ebner FH; Schittenhelm J
J Clin Pathol; 2014 Jul; 67(7):556-61. PubMed ID: 24607494
[TBL] [Abstract][Full Text] [Related]
37. The Use of Three Long Non-Coding RNAs as Potential Prognostic Indicators of Astrocytoma.
Zhi F; Wang Q; Xue L; Shao N; Wang R; Deng D; Wang S; Xia X; Yang Y
PLoS One; 2015; 10(8):e0135242. PubMed ID: 26252651
[TBL] [Abstract][Full Text] [Related]
38. Correlation of microRNA-375 downregulation with unfavorable clinical outcome of patients with glioma.
Chang C; Shi H; Wang C; Wang J; Geng N; Jiang X; Wang X
Neurosci Lett; 2012 Dec; 531(2):204-8. PubMed ID: 23103713
[TBL] [Abstract][Full Text] [Related]
39. Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma.
Wang Z; Cai H; Lin L; Tang M; Cai H
Pediatr Blood Cancer; 2014 Feb; 61(2):206-10. PubMed ID: 24038809
[TBL] [Abstract][Full Text] [Related]
40. Proteomics of tumor-specific proteins in cerebrospinal fluid of patients with astrocytoma: usefulness of gelsolin protein.
Ohnishi M; Matsumoto T; Nagashio R; Kageyama T; Utsuki S; Oka H; Okayasu I; Sato Y
Pathol Int; 2009 Nov; 59(11):797-803. PubMed ID: 19883430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
